COPD drug accepted by NHS Scotland

Scotland's drug watchdog has accepted a new maintenance therapy for COPD for use in the NHS.

Consultation: GPs in Scotland now have further options for COPD
Consultation: GPs in Scotland now have further options for COPD

The decision by the Scottish Medicines Consortium (SMC) to accept aclidinium widens the choice for GPs treating COPD in adults.

Until now, tiotropium was the only other licensed long-acting muscarinic antagonist (LAMA) accepted for use in NHS Scotland.

Aclidinium, which is inhaled twice daily using the Genuair dry powder inhaler device, was found to improve lung function versus placebo after 12 and 24 weeks.

Results from two RCTs submitted by manufacturer Almirall showed both peak and trough FEV1 improved in the aclidinium group compared with placebo. Side effects were similar or less than with placebo.

A study comparing the six-week clinical effectiveness of aclidinium versus tiotropium is ongoing.

The SMC noted that due to the lower annual cost of aclidinium versus current standard care, the NHS could save over £400,000 within five years as use of the drug increases.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Pension tax solution for judges shows government could do more for doctors, says BMA

Pension tax solution for judges shows government could do more for doctors, says BMA

Government plans to 'effectively exempt judges from pension tax' show the government...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Second-phase COVID-19 vaccine rollout maintains prioritisation by age

Second-phase COVID-19 vaccine rollout maintains prioritisation by age

The Joint Committee on Vaccination and Immunisation (JCVI) has published advice on...

PCNs paid £70m for first-wave COVID-19 jab campaign as NHS plots next phase of rollout

PCNs paid £70m for first-wave COVID-19 jab campaign as NHS plots next phase of rollout

Primary care network (PCN) COVID-19 vaccination sites have been paid £70m this month...

London GP personally calling at-risk patients to boost COVID-19 vaccine uptake

London GP personally calling at-risk patients to boost COVID-19 vaccine uptake

London GP Dr Farzana Hussain is personally telephoning scores of patients who have...

Half of patients with possible cancer symptoms avoided contacting GP in first wave

Half of patients with possible cancer symptoms avoided contacting GP in first wave

Almost half of people who experienced potential cancer symptoms in the first wave...